Jove
Visualize
Contact Us

Related Experiment Videos

Motor neurone disease.

K Talbot1

  • 1Department of Clinical Neurology, Radcliffe Infirmary, Oxford OX2 6HE, UK. kevin.talbot@clneuro.ox.ac.uk

Postgraduate Medical Journal
|October 3, 2002
PubMed
Summary
This summary is machine-generated.

Motor neurone disease (MND), also known as amyotrophic lateral sclerosis (ALS), is a fatal neurodegenerative condition. While a cure remains elusive, research into genetic subtypes offers hope for future treatments for both familial and sporadic forms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia.

Molecular psychiatry·2025
Same author

Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2022
Same author

Measuring coping in people with amyotrophic lateral sclerosis using the Coping Index-ALS: A patient derived, Rasch compliant scale.

Journal of the neurological sciences·2021
Same author

The sensory and affective components of pain: are they differentially modifiable dimensions or inseparable aspects of a unitary experience? A systematic review.

British journal of anaesthesia·2019
Same author

Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Development and validation of Spasticity Index-Amyotrophic Lateral Sclerosis.

Acta neurologica Scandinavica·2018
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
Same journal

Aids to venesection and parenteral drug administration in patients with difficult veins.

Postgraduate medical journal·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Neurology
  • Neuroscience
  • Genetics

Background:

  • Motor neurone disease (MND), or amyotrophic lateral sclerosis (ALS), is a progressive neurodegenerative disorder with unknown causes.
  • The condition leads to motor weakness and bulbar dysfunction, often resulting in premature death from respiratory failure.
  • Early diagnosis can be challenging due to the gradual manifestation of clinical features.

Purpose of the Study:

  • To review the diagnostic challenges and differential diagnoses of MND/ALS.
  • To discuss the genetic basis of familial ALS and its implications for sporadic forms.
  • To outline current supportive management strategies and explore potential future therapeutic avenues.

Main Methods:

  • Literature review of existing studies on MND/ALS.

Related Experiment Videos

  • Analysis of diagnostic criteria and differential diagnoses.
  • Examination of genetic findings and emerging treatment strategies.

    • Main Results:

    • MND/ALS diagnosis requires specialist neurological assessment due to complex differential diagnoses, including treatable conditions.
    • Genetic factors are implicated in a subset of familial ALS cases, providing insights into disease mechanisms.
    • Current management is supportive and multidisciplinary, as curative or disease-modifying therapies are unavailable.

    Conclusions:

    • Future treatments for MND/ALS may involve molecular-based therapies or stem cell interventions, potentially addressing both inherited and environmental factors.
    • Understanding the biological basis of genetic subtypes is crucial for developing effective treatments.
    • A multidisciplinary approach is essential for supportive care in the absence of definitive therapies.